bezlotoxumab

Bezlotoxumab is a medication used to prevent recurrences of Clostridium difficile infection, a serious intestinal infection often linked to antibiotic use. It works by targeting and neutralizing a toxin produced by the bacteria, thereby reducing the risk of the infection returning. This treatment is usually given to patients who have diarrhea caused by Clostridium difficile and are receiving antibiotics. It is administered via an intravenous infusion, meaning it is delivered directly into the bloodstream. Bezlotoxumab is an important option for improving recovery and reducing the chances of repeat infections in affected patients.